Evanthia Roussos Torres, MD, PhD

home / authors / evanthia-roussos-torres-md-phd

Articles

What’s Next for the HER2-Negative Breast Cancer Space?

August 11th 2022

Evanthia Roussos Torres, MD, PhD, discusses the next steps and novel therapies currently showing promise in the HER-2 negative breast cancer space.

Next Steps After Trial of Entinostat for Advanced Breast Cancer

Evanthia Roussos Torres, MD, PhD

December 6th 2021

Evanthia Roussos Torres, MD, PhD, discusses the follow-up research related to the phase 1 study of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.

Triplet Therapy Shows Efficacy in Phase 1 Advanced Breast Cancer Trial

Evanthia Roussos Torres, MD, PhD

November 20th 2021

Evanthia Roussos Torres, MD, PhD, discusses the phase 1 study of the efficacy of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.